202 related articles for article (PubMed ID: 34220581)
1. Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression.
Gilbert JR; Galiano CS; Nugent AC; Zarate CA
Front Psychiatry; 2021; 12():673159. PubMed ID: 34220581
[TBL] [Abstract][Full Text] [Related]
2. Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.
Gilbert JR; Yarrington JS; Wills KE; Nugent AC; Zarate CA
Int J Neuropsychopharmacol; 2018 Aug; 21(8):740-747. PubMed ID: 29668918
[TBL] [Abstract][Full Text] [Related]
3. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.
Lundin NB; Sepe-Forrest L; Gilbert JR; Carver FW; Furey ML; Zarate CA; Nugent AC
J Affect Disord; 2021 Jan; 279():239-249. PubMed ID: 33074143
[TBL] [Abstract][Full Text] [Related]
4. Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.
Muthukumaraswamy SD; Shaw AD; Jackson LE; Hall J; Moran R; Saxena N
J Neurosci; 2015 Aug; 35(33):11694-706. PubMed ID: 26290246
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder.
Nugent AC; Ballard ED; Gilbert JR; Tewarie PK; Brookes MJ; Zarate CA
Front Psychiatry; 2020; 11():519. PubMed ID: 32655423
[TBL] [Abstract][Full Text] [Related]
6. Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine.
Sumner RL; McMillan RL; Forsyth A; Muthukumaraswamy SD; Shaw AD
Transl Psychiatry; 2024 Feb; 14(1):116. PubMed ID: 38402231
[TBL] [Abstract][Full Text] [Related]
7. Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Cornwell BR; Salvadore G; Furey M; Marquardt CA; Brutsche NE; Grillon C; Zarate CA
Biol Psychiatry; 2012 Oct; 72(7):555-61. PubMed ID: 22521148
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression.
de la Salle S; Phillips JL; Blier P; Knott V
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Apr; 115():110507. PubMed ID: 34971723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.
Bottemanne H; Morlaas O; Claret A; Sharot T; Fossati P; Schmidt L
JAMA Psychiatry; 2022 Nov; 79(11):1124-1132. PubMed ID: 36169969
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.
Machado-Vieira R; Yuan P; Brutsche N; DiazGranados N; Luckenbaugh D; Manji HK; Zarate CA
J Clin Psychiatry; 2009 Dec; 70(12):1662-6. PubMed ID: 19744406
[TBL] [Abstract][Full Text] [Related]
11. Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression.
Ballard ED; Greenstein D; Reiss PT; Crainiceanu CM; Cui E; Duncan WC; Hejazi NS; Zarate CA
Transl Psychiatry; 2024 Jun; 14(1):238. PubMed ID: 38834540
[TBL] [Abstract][Full Text] [Related]
12. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
Neuroimage Clin; 2018; 20():92-101. PubMed ID: 30094160
[TBL] [Abstract][Full Text] [Related]
13. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.
Ibrahim L; Diazgranados N; Franco-Chaves J; Brutsche N; Henter ID; Kronstein P; Moaddel R; Wainer I; Luckenbaugh DA; Manji HK; Zarate CA
Neuropsychopharmacology; 2012 May; 37(6):1526-33. PubMed ID: 22298121
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
[TBL] [Abstract][Full Text] [Related]
15. Can 'floating' predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression.
Acevedo-Diaz EE; Cavanaugh GW; Greenstein D; Kraus C; Kadriu B; Park L; Zarate CA
J Psychiatr Res; 2020 Nov; 130():280-285. PubMed ID: 32861983
[TBL] [Abstract][Full Text] [Related]
16. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Phillips JL; Norris S; Talbot J; Birmingham M; Hatchard T; Ortiz A; Owoeye O; Batten LA; Blier P
Am J Psychiatry; 2019 May; 176(5):401-409. PubMed ID: 30922101
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
[TBL] [Abstract][Full Text] [Related]
18. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.
Mathew SJ; Murrough JW; aan het Rot M; Collins KA; Reich DL; Charney DS
Int J Neuropsychopharmacol; 2010 Feb; 13(1):71-82. PubMed ID: 19288975
[TBL] [Abstract][Full Text] [Related]
19. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
[TBL] [Abstract][Full Text] [Related]
20. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
